The BCAM gene helps make a protein on the surface of red blood cells and some other cells, where it supports cell attachment and contributes to the Lutheran blood group. If this gene does not work as expected, the way cells stick to nearby tissues can change, which may affect blood group testing and how red blood cells interact with blood vessel walls. This gene plays an important role in cell attachment, especially in the bloodstream. Some variants in the BCAM gene are linked to rare Lutheran blood group differences.
What is a gene?
A gene is a piece of DNA that holds instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others are used mainly to guide when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you react to food, stress, or medicines. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
BCAMGene function
What if the gene works
The BCAM gene helps make a protein on the cell surface that lets some cells, including red blood cells, attach to surrounding support tissue. This supports cell shape and the Lutheran blood group system.
Risk
What if the gene does not work
Changes in the BCAM gene can weaken or remove the BCAM surface protein on red blood cells and tissues, reducing laminin binding. Milder variants may partly lower this binding, while more severe variants can abolish the Lutheran blood group protein.
Treatment
What does that mean for your treatment
No treatment or drug choice is currently guided by variants in the BCAM gene. The BCAM gene is being studied as a cell adhesion biomarker and possible drug target, including in sickle cell disease and some cancers, but this has not led to guideline based therapy.
Gene function
What if the gene works
Cells use the BCAM gene to help them hold onto their surroundings in a steady way. Its protein sits on the cell surface and can latch onto laminin, a support protein in the tissue scaffold around cells. Understanding how the BCAM gene works in the body makes its everyday role in cell attachment easier to see.
The BCAM gene makes a surface protein that helps cells attach to laminin, a support protein in the tissue scaffold around them. This steady contact helps cells stay positioned and connected to their surroundings.
Many body linings need controlled contact between cells and the layer beneath them. BCAM supports this contact, which helps keep tissue surfaces organized during routine wear and repair.
On red blood cells, BCAM provides one of the surface points that can interact with laminin during normal cell contact. The same protein also carries Lutheran blood group markers used to classify blood types in transfusion testing.
What is a variant?
A genetic variant is a small change in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the BCAM gene can change the shape of this protein, lower how much reaches the red blood cell surface, or stop it from being made at all. Some BCAM gene variants cause small shifts in Lutheran blood group sites, while more disruptive variants can leave little or no working protein, leading to low or absent Lutheran antigen expression. This functional range means milder changes may partly reduce protein activity, whereas severe loss-of-function variants can remove it completely.
How variants are linked to conditions
Current evidence suggests the BCAM gene does not yet have a broadly confirmed link to a specific health condition, although research on how BCAM gene variants are linked to conditions continues to grow. Anyone with a confirmed BCAM-related diagnosis should rely on guidance from their doctor or genetic counselor rather than general information.
A variant is not necessarily a diagnosis
Variants in genes are a normal feature of human biology and are widely found in the general population. Most do not have a direct impact on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a clear diagnosis, especially when more than one gene and environmental factors are part of the picture. In some cases, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risks related to the BCAM gene. In some settings, BCAM may interact with other health conditions rather than act alone, so overall risk can depend on the bigger medical picture. Anyone worried about personal or family risk can talk with a doctor or genetic counselor.
Inheritance of BCAM variants
There is not yet a broadly confirmed Mendelian inheritance pattern tied to a specific BCAM-related medical condition, so the answer to how BCAM gene variants are inherited remains limited to general genetics rather than a single dominant or recessive pattern. The BCAM gene is located on chromosome 19, which is an autosome. That means you inherit two copies of the BCAM gene, one from each parent.
What does my BCAM result mean for my family?
There isn't yet a broadly confirmed inheritance pattern tied to a specific health condition for BCAM, though this can change as research develops. BCAM is best known for helping determine a blood group feature rather than a clearly inherited disease pattern. If you have a specific BCAM result and questions about what it could mean for your family, a doctor or genetic counselor can help explain it in the right context.
Genetic information
Genetic testing
How you find out about variants
BCAM genetic testing checks a blood or saliva sample for changes in the BCAM gene. In practice, how BCAM genetic testing works is straightforward: a lab reads the gene’s DNA sequence and compares it with a reference sequence to identify variants for medical interpretation.
When should I consider getting a genetic test?
There is not yet a broadly established reason for most people to have genetic testing focused on the BCAM gene. Testing may be considered with a doctor or genetic counselor if there are unusual blood-matching results, transfusion questions, or a family history that suggests a rare inherited blood-group difference.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it reveals depends on the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, shape how the body functions over time. For some conditions, especially those affected by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. This is common and helps explain why the same treatment works well for one person but less well for another. It can also influence how sensitive someone is to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect medication response. By looking at connections between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug acts and how the body processes it. This information can support more informed, individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the BCAM gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choices, so questions about medications, side effects, or treatment changes are best discussed with your doctor.
History
The BCAM gene first entered medical history through blood group research rather than through a widely known public story. In the mid 20th century, doctors identified the Lutheran blood group after unusual antibodies were found during blood testing, and later work showed that these blood group markers are carried by the protein made from the BCAM gene. Initially understood only through visible traits, later recognized as tied to a specific gene, this system became part of routine transfusion medicine. Building on this early work, scientists mapped the Lutheran blood group to chromosome 19 and clarified its genetic basis. These steps helped make blood matching more precise for people who carry uncommon Lutheran blood group variants.